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Background: The aims of the study were to investigate the factors associated with not having breast
reconstruction following mastectomy and to assess patient satisfaction with information on reconstruction.
Patients and methods: We analysed a historical cohort of 1937 consecutive patients who underwent mastectomy
at Institut Curie between January 2004 and February 2007. Their sociodemographic and clinicobiological
characteristics were recorded in a prospective database. A questionnaire was sent to 10% of nonreconstructed
patients.
Results: The proportion of patients with invasive cancer was 82.7%. The rate of nonreconstruction in patients with
in situ and invasive cancer was 34.6% and 74.9%, respectively. On multivariate analysis, only employment outside
the home was associated with reconstruction in patients with in situ cancer (p < 0.001). In patients with invasive
cancer, employment status (p < 0.001) and smoking (p = 0.045) were associated with reconstruction, while age > 50,
ASA score >1, radiotherapy (p < 0.0001) and metastatic status (p = 0.018) were associated with nonreconstruction.
For 80% of questionnaire responders, nonreconstruction was a personal choice, mainly for the following reasons:
refusal of further surgery, acceptance of body asymmetry, risk of complications and advanced age. Information on
reconstruction was entirely unsatisfactory or inadequate for 62% of patients.
Conclusion: Better understanding the factors that influence decision of nonreconstruction can help us adapt the
information to serve the patient’s personal needs.
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About 52,500 women are diagnosed with breast cancer
in France every year (La situation du cancer en France
2010). Breast-conserving therapy is standard procedure
for selected patients (Fisher et al. 2002; Veronesi et al.
1995), however, between 2005 and 2009, 26% of breast
cancer patients in France underwent mastectomy (La
situation du cancer en France 2010). Only 22.9% of* Correspondence: severine.alran@curie.net
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in any medium, provided the original work is ppatients who undergo mastectomy in France proceed
with reconstruction (PMSI national 2011).
Mastectomy and reconstruction rates vary widely from
between countries, regionally within countries and over
time, making it difficult to produce meaningful compa-
risons. Nevertheless, what emerges across all studies is
that the majority patients do not have reconstruction
following mastectomy (Table 1) (Kruper et al. 2011;
Jeevan et al. 2010; Hvilsom et al. 2011; Morrow et al.
2001; Reaby 1998; Baxter et al. 2005; Yu et al. 2007;
Meyer-Marcotty et al. 2007; Fallbjork et al. 2010;
Al-Allak et al. 2010; Al-Ghazal et al. 2000; Harcourt et al.
2003; Christian et al. 2006; Joslyn 2005; Rowland et al.an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Table 1 Reconstruction rates in various countries
Author Country Type of study sample size Mastectomy rate Reconstruction rate
Reaby et al. (1998) Australia Questionnaire N = 95 – 10%
Baxter et al. (2005) Canada Retrospective N = 27 718 42.9% 7.9%
Yu et al.(2007) China Retrospective N = 5887 93.7% 5%
Hvilsom et al. (2011) Denmark National registry N = 13 379 37% 25%
Meyer-Marcotty et al. (2007) Germany Retrospective N = 4335 34% 13%
Fallbjork et al. (2010) Sweden Questionnaire N = 149 40% 25%
Al-Allak et al.(2010) United Kingdom Retrospective N = 272 – 46%
Al-Ghazal et al. (2000) United Kingdom Retrospective N = 577 35% 21%
Harcourt et al. (2003) United Kingdom Prospective N = 103 – 46%
Jeevan et al. (2010) United Kingdom Registry N = 44 837 40% 16%
Christian et al. (2006) United States National registry N = 2174 42% 42%
Joslyn (2005) United States National registry N = 27 703 – 17%
Kruper et al. (2011) United States State registry N = 11 019 42% 25-29%
Morrow et al. (2001) United States National registry N = 68 348 – 8.3%
Rowland et al. (2000) United States Retrospective N = 1957 43% 17%
Our study Héquet et al. France Retrospective N = 1937 Questionnaire N = 132 26% 32.1%
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and timing of breast reconstruction, patient satisfaction
and quality-of-life after reconstruction, as well as the
relative mastectomy/reconstruction rates, and the factors
affecting these rates. These studies tend to focus on pa-
tients who undergo reconstruction. A few studies have
given equal importance to patients who do not have re-
construction (Morrow et al. 2001; Reaby 1998; Fallbjork
et al. 2010; Harcourt et al. 2003; Alderman et al. 2003).
To our knowledge, this was the first recent study that
proposed to focus specifically on patients who did not
have surgical reconstruction. The aim was to gain a
better understanding of the factors, both medical and
personal, that led to the decision and to consider the im-
plications in terms of patient management and counse-
ling. To that end, we assessed the sociodemographic and
clinicobiological factors associated with surgical recon-
struction in patients who did not have reconstruction
and in patients who did, whether immediate or delayed.
In addition, we investigated the reasons why patients did
not have surgical reconstruction, and evaluated the in-
formation provided to these patients.
Patients and methods
Study population
Consecutive patients treated by mastectomy for in situ
or invasive breast cancer between January 2004 and
December 2007 in Institut Curie (Paris, France), were
eligible for inclusion. Exclusion criteria were history of
contralateral mastectomy, bilateral mastectomy, mas-
tectomy for benign disease, prophylactic mastectomy,
and men. The study was approved by the Breast CancerStudy Group of Institut Curie, and the questionnaire
was approved by the Ethics Committee of Institut Curie.
Data collection
Data in the medical charts of a historical cohort of 1937
patients were prospectively recorded for analysis. The
following factors were studied: age at mastectomy, ma-
rital status, professional status, weight (in kg), height
(in cm), breast size, American Society of Anesthesiolo-
gists (ASA) score, histological grade of cancer (in situ
carcinoma, invasive carcinoma grade I, II, III of the
Scarff-Bloom-Richardson classification), tumor size (in
cm), estrogen-receptor status, progesterone-receptor sta-
tus, HER2 status, axillary lymph node status, indication
of mastectomy (for clinicobiological factors of cancer,
after failure of conservative treatment, or for recur-
rence), and adjuvant therapy (hormone therapy, chemo-
therapy, radiotherapy).Questionnaire
A questionnaire was sent to a 10% sample of patients
who did not have reconstruction (n = 132), including
every tenth patient in the retrospective database. The
questionnaire was prepared in collaboration with a panel
of 8 patients who had undergone mastectomy only and a
panel of medical and paramedical professionals working
in the field of breast cancer. The questionnaire was sent
out in June 2011. Responders remained anonymous.
All questions were multiple choice, and patients could
provide more than one response. At the end of the
questionnaire, free-text comments could be added. The
Table 2 Characteristics of the population
All patients (N = 1937)
Age (years) - median (range) 56 (23–97)
Marital status - N (%)
Not partnered 411 (21.3)
Partnered 651 (33.6)
Unknown 875 (45.1)
Employment status - N (%)
Not working outside home 609 (31.4)
Working outside home 900 (46.5)
Unknown 428 (22.1)




>30 Unknown 221 (11.4) 49 (2.5)
Breast size (cm) - median (range) 90 (65–130)






Tobacco users - N (%) 296 (15.3)
ASAb score - N (%)
ASA 1 1051 (54.2)
ASA 2 824 (42.6)
ASA >2 62 (3.2)
Histologic stage - N (%)
In situ 335 (17.3)
SBRc I 217 (11.2)
SBR II 716 (37)
SBR III 614 (31.7)
Invasive SBR unknown 54 (2.8)





Estrogen receptors positive - N (%) 1251 (64.6)
Progesterone receptors positive - N (%) 444 (22.9)
Overexpression HER2 - N (%) 228 (11.8)
Axillary lymph nodes positive - N (%) 726 (37.5)
Inflammatory cancer - N (%) 92 (4.8)
Metastatic cancer - N (%) 83 (4.3)
Indication of mastectomy - N (%)
Table 2 Characteristics of the population (Continued)
Clinicobiological characteristics of cancer 1061 (54.8)
Failure conservative surgery 357 (18.4)
Local recurrence 519 (26.8)
Chemotherapy - N (%)
Adjuvant 715 (36.9)
Neoadjuvant 284 (14.7)
Radiotherapy - N (%) 971 (50.2)
Hormone therapy - N (%) 1175 (60.7)
a BMI body mass index.
b ASA American Society of Anesthesiologists.
c SBR Scarff-Bloom-Richardson grade.
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ments were collected.
Analysis
The sociodemographic and clinicobiological factors asso-
ciated with reconstruction were assessed in two groups:
patients who did not have reconstruction and patients
who had immediate or delayed reconstruction. Univa-
riate analysis was performed using Chi-square test for
categorical variables and Student’s t-test for continuous
variables. Multivariate analysis was performed using lo-
gistic regression models on two groups: patients with in
situ cancer and patients with invasive cancer. Variables
associated with reconstruction (P < 0.10) in the univari-
ate analysis were introduced into the multivariate model,
as more traditional approaches, such as considering all
variables with P < 0.05 in the univariate analysis, can fail to
identify variables known to be important. A P-value < 0.05
was considered statistically significant.
Results
Description of the cohort
Among the 1937 patients included, 1315 (67.9%) had no
surgical reconstruction and 622 (32.1%) patients had
surgical reconstruction, which was immediate in 363
patients (58.5%) and delayed in 259 patients (41.5%).
Among patients who ultimately had delayed reconstruc-
tion, the median time to reconstruction was 19 months
(range: 3–77 months).
Patient characteristics are summarized in Table 2.
Factors associated with not having surgical breast
reconstruction
In situ cancer
Mastectomy was indicated for in situ cancer in 335
patients (17.3%). The nonreconstruction rate was
34.6%. The reconstruction rate was 65.4% immediate
in 82.6% of cases and delayed in only 17.4% of cases.
Univariate analysis showed a statistical difference between
Table 3 Univariate analysis in 335 patients with in situ cancer
Nonreconstructed N = 116 Reconstructed N = 219 P-value
Age (years) - median (range) 57 (23–86) 50 (26–75) < 0.001
Marital status - N (%) 0.134
Not partnered 28 (42.4) 40 (30.5)
Partnered 38 (57.6) 91 (69.5)
Employment status - N (%) < 0.001
Not working outside home 46 (48.9) 39 (21.3)
Working outside home 48 (51.1) 144 (78.7)
BMIa (kg/m2) - N (%) 0.391
<20 23 (20.2) 42 (19.3)
20-25 59 (51.8) 123 (56.4)
26-30 20 (17.5) 41 (18.8)
>30 12 (10.5) 12 (5.5)
Tobacco users - N (%) 15 (12.9) 38 (17.4) 0.369
ASAb score - N (%) 0.004
ASA 1 64 (55.2) 157 (71.7)
ASA 2 48 (41.4) 60 (27.4)
ASA >2 4 (3.4) 2 (0.9)
Tumor size (cm) - N (%) 0.123
<2 29 (27.1) 41 (23.7)
2-5 56 (52.3) 77 (44.5)
>5 22 (20.6) 55 (31.8)
Indication of mastectomy - N (%) 0.612
Clinicobiological characteristics of cancer 57 (49.1) 96 (43.8)
Failure conservative surgery 39 (33.6) 78 (35.6)
Local recurrence 20 (17.2) 45 (20.5)
a BMI body mass index.
b ASA American Society of Anesthesiologists.
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factors (Table 3). Reconstructed patients were 7 years
younger than nonreconstructed patients (P < 0.001). Not
working outside the home was more frequent in nonre-
constructed patients (48.9% versus 21.3%, P < 0.001).
Twenty-eight percent of reconstructed patients had
an ASA score above 1, while 44.8% of nonreconstructed
patients had a score above 1 (P = 0.004).
In the multivariate analysis, only employment status
was statistically different between the 2 groups, with 4
times more patients in the reconstructed group working
outside the home (OR: 4.05; CI: 2.05-8.00; P < 0.001). No
statistically significant difference was found for the other
criteria (Table 4).Invasive cancer
Mastectomy was indicated for invasive cancer in 1602
patients (82.7%). The nonreconstruction rate was 74.9%.The reconstruction rate was 25.1% immediate in 45% of
cases and delayed in 55% of cases.
Univariate analysis showed that reconstructed patients
were 9 years younger than nonreconstructed patients
(Table 5). Forty-nine percent of nonreconstructed pa-
tients were not working outside the home, compared to
only 22% of reconstructed patients (P < 0.001). High Body
Mass Index (>25 kg/m2) was more frequent in non-
reconstructed patients (41.1% versus 27.7%, P < 0.001).
Smoking was more frequent in reconstructed patients
(20.9% versus 13.3%, P < 0.001). Positive axillary lymph-
node or metastatic status was more frequent in nonre-
constructed patients (48.3% versus 36.5%, P < 0.001 and
6.4% versus 2.2%, P = 0.002 respectively). Radiotherapy
was more frequent in nonreconstructed patients (60%
versus 52.7%, P = 0.012).
In the multivariate analysis, reconstruction was less
frequent when the following factors were present: age
over 50 (OR: 0.22; CI: 0.11-0.44; P < 0.001), ASA score
Table 4 Multivariate analysis for breast reconstruction
Patients with in situ cancer N = 335 Patients with invasive cancer N = 1602
ORa CIb P-value OR CI P-value
Age (years) 0.091 < 0.001
<35 1.00 1.00
35-50 0.92 0.23-3.72 0.45 0.24-0.86
>50 0.45 0.11-1.84 0.22 0.11-0.44
Employment status < 0.001 < 0.001
Not working outside home 1.00 1.00
Working outside home 4.05 2.05-8.00 2.07 1.37-3.13
BMIc (kg/m2) 0.420 0.078
<20 1.00 1.00
20-25 1.79 0.80-4.00 1.30 0.83-2.02
26-30 2.21 0.81-6.03 0.80 0.46-1.38




ASAd score 0.155 < 0.001
ASA 1 1.00 1.00
ASA 2 0.63 0.33-1.19 0.51 0.36-0.73
ASA >2 0.00
Tumor size (cm) 0.232 0.655
<2 1.00 1.00
2-5 0.58 0.27-1.24 1.09 0.75-1.58




Indication of mastectomy 0.024
Clinicobiological characteristics of cancer 1.00
Failure conservative surgery 1.27 0.84-1.91








a OR odds ratio.
b CI confidence interval.
c BMI body mass index.
d ASA American Society of Anesthesiologists.
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status (OR: 0.34; CI: 0.13-0.91; P = 0.018), and radiothe-
rapy (OR: 0.57; CI: 0.38-0.86; P < 0.001). The followingfactors were associated with reconstruction: working
outside the home (OR: 2.07; CI: 1.37-3.13; P < 0.001),
smoking (OR: 1.52; CI: 1.01-2.28; P = 0.045), HER2
Table 5 Univariate analysis in 1602 patients with invasive cancer
Nonreconstructed N = 1200 Reconstructed N = 402 P-value
Age (years) - median (range) 59.6 (28–97) 50.5 (25–76) < 0.001
Marital status - N (%) 0.171
Not partnered 266 (41.1) 77 (35.5)
Partnered 382 (59) 140 (64.5)
Employment status - N (%) < 0.001
Not working outside home 457 (49.4) 67 (21.9)
Working outside home 469 (50.6) 239 (78.1)
BMIa (kg/m2) - N (%) < 0.001
<20 158 (13.6) 69 (17.5)
20-25 527 (45.3) 216 (54.8)
26-30 317 (27.3) 72 (18.3)
>30 160 (13.8) 37 (9.4)
Tobacco users - N (%) 159 (13.3) 84 (20.9) < 0.001
ASAb score - N (%) < 0.001
ASA 1 557 (46.5) 272 (67.7)
ASA 2 588 (49) 128 (31.8)
ASA >2 54 (4.5) 2 (0.05)
Tumor size (cm) - N (%) 0.004
<2 377 (32) 156 (40.9)
2-5 619 (52.6) 167 (43.8)
>5 181 (15.4) 58 (15.2)
Axillary lymph nodes positive N (%) Median (range) 579 (48.3%) 1 (0–28) 147 (36.5) 0 (0–19) < 0.001
Metastatic cancer - N (%) 76 (6.4) 9 (2.2) 0.002
Indication of mastectomy - N (%) < 0.001
Clinicobiological characteristics of cancer 720 (60.1) 187 (46.5)
Failure conservative surgery 162 (13.5) 78 (19.4)
Local recurrence 317 (26.4) 137 (34.1)
Chemotherapy - N (%) 0.253
Adjuvant 501 (41.8) 187 (46.5)
Neoadjuvant 208 (17.3) 64 (15.9)
Radiotherapy - N (%) 720 (60) 212 (52.7) 0.012
Hormone therapy - N (%) 853 (71.1) 283 (70.4) 0.825
a BMI body mass index.
b ASA American Society of Anesthesiologists.
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mastectomy indicated for local recurrence (OR: 2.09; CI:
1.23-3.55; P = 0.024). The results are presented in Table 4.
Reasons for not having surgical reconstruction
The response rate to the questionnaire was 61.4% (81
patients).
Forty-nine patients (80%) declared that the decision
not to have reconstruction was a personal choice. Eleven
patients (18%) declared that reconstruction was not
offered by the surgeon. Twelve patients (19.7%) de-
clared that the decision was a personal choice andthat reconstruction was not offered by the surgeon.
Five patients (8.2%) declared that reconstruction was
not undertaken for medical reasons.
The reasons for deciding not to have reconstruction,
among patients who declared that the decision was a
personal choice, are shown in Table 6.Evaluation of information on surgical breast reconstruction
Analysis of the responses to questions concerning the
source of information on reconstruction and patient sa-
tisfaction is shown in Table 6.
Table 6 Analysis of questionnaire data
N %
Questionnaires sent out 132 100
Questionnaires returned 81 61.4
Non-respondents (i.e. refused to participate, deceased or subsequently reconstructed) 20 24.7
Respondents 61 75.3
Reason for nonreconstruction
Personal choice 33 54.1
Not offered by surgeons and personal choice 12 19.7
Not offered by surgeons 11 18
Medical reasons and personal choice 4 6.6
Medical reasons 1 1.6
Personal choice
Refusal of further surgery 36 59
Acceptance of body asymmetry 23 37.7
Risk of complications 18 29.5
Advanced age 14 23
Fear of masking recurrence 11 18
Acceptance of body asymmetry by partner 11 18
Financial cost 9 14.8
Post-mastectomy pain 4 6.6
Source of information on reconstruction
Surgeon at ICa 21 34.4
Plastic surgeon at IC 8 13.1
Physician outside IC 7 11.5
Physician or nurse at IC 7 11.5
Relative with history of reconstruction 6 8.8
Internet, review, magazine 5 8.2
Patients association 3 4.9
IC website or review 3 4.9
Plastic surgeon outside IC 2 3.3
Satisfaction with information on reconstruction
Entirely unsatisfactory 25 41
Inadequate 13 21.3
Adequate 17 27.9
Entirely satisfactory 6 9.8
a IC Institut Curie.
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In France, the reconstruction rate is around 23% (PMSI
national 2011). The rate is 32.1% at Institut Curie, a na-
tional cancer institute in Paris. Other studies have shown
that reconstruction rates tend to be higher in specialized
cancer-treatment centers (Kruper et al. 2011; Jeevan
et al. 2010; Hvilsom et al. 2011; Morrow et al. 2001), and
our study supports this finding, with a reconstruction
rate well above the national average.Previous studies have shown that younger patients are
more likely to have reconstruction compared to older
patients (Kruper et al. 2011; Jeevan et al. 2010; Morrow
et al. 2001; Reaby 1998; Fallbjork et al. 2010; Al-Allak
et al. 2010; Christian et al. 2006; Joslyn 2005; Rowland
et al. 2000). In our study, age over 50 was significantly
associated with nonreconstruction in patients with inva-
sive cancer, but only approached significance in patients
with in situ cancer. It has been theorized that this
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older women attach less importance to body image, or
that they have more comorbidities. A recent review on
reconstruction in older patients cites the fear of compli-
cations as a major dissuasive factor, even though studies
have shown that age in itself is not a risk factor for poor
surgical outcomes (Walton et al. 2011).
Pathology tumor stage has also been shown to be an
important predictor of nonreconstruction (Morrow et al.
2001; Christian et al. 2006; Joslyn 2005). In our study,
patients with primary invasive cancer were much less
likely to undergo reconstruction than those with in situ
cancer or local recurrence. The probable explanation is
that, in the latter two cases, reconstruction can be per-
formed at the same time as mastectomy, thereby limiting
the number of additional surgical interventions, as illus-
trated by the fact that, in almost 83% of patients with in
situ cancer who had reconstruction, the procedure was
immediate. In addition, these patients did not receive
post-operative radiotherapy. In our study, in patients
with invasive cancer, radiotherapy significantly reduced
the odds of having reconstruction, however confounding
factors may be present, including cancer stage and type
of reconstruction. In most patients with a history of
radiotherapy, autologous reconstruction is required be-
cause the complication rate with implant-based re-
construction is greater than 40% (Barry & Kell 2011;
Kronowitz & Robb 2009). The advantages and disad-
vantages of the different techniques enter into the pa-
tient’s final decision as concerns delayed reconstruction
(Alderman et al. 2002; Cordeiro & McCarty 2006;
Rouzier et al. 2000).
For the majority of patients, the decision not to have
nonreconstruction was reportedly a personal choice. The
major reason was refusal of further surgery. Clearly it is
legitimate for patients to be reluctant to have surgery
that is not necessarily perceived to be an integral part of
treatment of the disease as such. Patients’ concerns
about the number of surgeries and the duration of re-
covery may outweigh the potential benefits in terms of
cosmesis and quality of life.
Acceptance of body asymmetry by the patient herself
and/or by her partner was frequently reported as the
reason for not having reconstruction. This finding points
to a potential weakness in the study, i.e. the fact that the
questionnaire was sent out several years after the initial
decision concerning reconstruction was taken. As a re-
sult, the responses probably reflect to some extent what
patients considered to be the reason(s) for not having re-
construction at the time of filling out the questionnaire.
Nevertheless, the decision is not necessarily taken ‘once
and for all’. The availability of delayed reconstruction
means that the option may remain open for several years
after mastectomy, as illustrated by the fact that, at thetime of analysis in our study, the median time to delayed
reconstruction was about 1½ years, with a maximum of
almost 6½ years. For this reason, while we recognize it
as a potential weakness, we do not believe that it under-
mines the validity of the finding.
The risk of complications was reported as the reason
for not having reconstruction by almost 30% of patients,
which is lower than the percentages seen in other stu-
dies (Shameem et al. 2008; Alderman & Jagsi 2010).
Endorsement of this reason indicates that the patients
were aware of the potential complications. Although
the source of the information could not be ascer-
tained, a recent review by Potter et al. highlights problems
in reporting outcomes in reconstruction, particularly as
concerns the assessment of surgical complications (Potter
et al. 2010).
Fear of masking recurrence of the disease was reported
by 18% of patients. Considerably higher percentages
have been reported elsewhere (Shameem et al. 2008;
Alderman & Jagsi 2010), even though studies going back
as far as the mid-1990s do not support the fear that re-
construction might interfere with postoperative cancer
surveillance. This finding has obvious implications in
terms of patient counseling, suggesting that, with better
information, patients might overcome their fear.
Age was not listed among the multiple-choice respon-
ses on the questionnaire, but was added in the free-text
section ‘Other reason(s)’ by almost a quarter of patients,
making this an important finding. The reasons why age
in itself should be a major factor have not been fully elu-
cidated, but certainly merit further investigation.
As expected, financial considerations were not a major
factor since, under the publicly funded healthcare system
in France, patients do not have to pay for the procedure,
theoretically at least. In practice, however, access to re-
construction in public institutions is restricted by the
limited number of surgeons and availability of operating
theaters. As a result, a number of patients in France are
led to consult in private hospitals, which entails addi-
tional costs, borne by the patient herself or by patient-
funded complementary health insurance. Financial cost
as a reason for not having reconstruction, as reported by
14% of patients, reflects a problem of access to the pro-
cedure within our institution.
Finally, post-mastectomy pain was reported by 6.5% of
patients. Similar to acceptance of body asymmetry, this
reason for not having reconstruction reflects the on-
going nature of the decision and is relevant only to pa-
tients who were offered or were considering delayed
reconstruction. It suggests the need for better control of
complications following mastectomy.
Sixty-one patients completed the questions related to
the source of and satisfaction with information on re-
construction. While the questionnaire did not preclude
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respondent cited two sources of information, pointing to
another potential weakness in our findings. More than
three-quarters of patients reported that the information
had been received from a medical source, most often
(63%) a source within Institut Curie: a surgeon, a plastic
surgeon, a doctor or nurse, or from the Institut website
or review (Table 6), however the actual proportion is
almost certainly even higher. Although provision of in-
formation is not recorded in patients’ files, standard pro-
cedures at Institut Curie make it nearly impossible for a
patient who is eligible for reconstruction not to be in-
formed of this option.
It is therefore noteworthy that, in 40% of patients
overall, the decision was taken after receiving informa-
tion they considered to be ‘entirely unsatisfactory’. A
similar figure was found in the National Mastectomy
and Breast Reconstruction Audit in 2010, in which
41.6% of mastectomy-only patients reported they had
been “given no information” (Mayor 2010). As concerns
our finding, it is probably not only a question of quantity
or even of quality, but also of timing and the method of
delivering information prior to mastectomy, i.e. at a time
when many patients may not be highly receptive.
Another study has been set up to investigate the
provision of information in our institution, involving pa-
tients and care-givers on an equal footing.Conclusions
The majority of patients with breast cancer who undergo
mastectomy do not proceed with breast reconstruction.
The decision involves multiple factors, some biological
and socio-demographic, as well as personal choice. Al-
most two-thirds of patients were unsatisfied with the
information they received. We believe efforts must be
made to improve the type and timing of delivering infor-
mation in order to ensure that patients receive the infor-
mation they require. By better understanding the factors
that the patient takes into consideration in making her
decision, we can adapt the information to serve the
patient’s personal needs and to support the patient in
making an informed personal choice on approaches to
reconstruction following mastectomy. Future studies
must be directed with patients themselves to improve
the type and timing of delivering information on diffe-
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